This artice is free to access.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of clevudine versus placebo, no intervention, or any of the nucleoside/nucleotide analogues, in people with chronic HBV infection.
Ricaforte-Campos, J. D., Benjamin, C. L. M., Nikolova, D., & Gluud, C. (2016). Clevudine in people with chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews, 2016(10). https://doi.org/10.1002/14651858.CD012411